Urology · Cherry Hill, NJ
NPI
1124192489
Since 2006
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2090 Springdale Rd Ste D
Cherry Hill, NJ, 08003
Phone (877) 388-2778
Groups this clinician bills Medicare through
Medicare paid, 2024
$878K
14,378 services
Medicare patients, 2024
1,439
Average age 75
Drug cost, 2024
$7.8M
5,449 prescriptions
Company payments, 2025
$245K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gordon A Brown was code J9155 (injection, degarelix, 1 mg), 3,360 times for 14 patients. In total Gordon A Brown billed 14,378 services in 109 codes, and Medicare paid $878K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9155 Injection, degarelix, 1 mg | Office | 3,360 | 14 | $3.33 | $11K |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,750 | 17 | $2.23 | $3,897 |
| 99213 Office E&M - Established | Office | 1,728 | 970 | $66.63 | $115K |
| 99214 Office E&M - Established | Office | 1,111 | 619 | $96.41 | $107K |
| 81003 Clinical Chemistry | Office | 859 | 570 | $2.19 | $1,881 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 660 | 73 | $140.49 | $93K |
| 51798 Ultrasound - Nonspecific | Office | 366 | 267 | $8.99 | $3,291 |
| 87086 Bacterial Culture | Office | 166 | 132 | $7.86 | $1,305 |
| 87088 Bacterial Culture | Office | 161 | 128 | $7.91 | $1,274 |
| 52000 Cystourethroscopy | Office | 159 | 110 | $196.10 | $31K |
| 96402 Chemotherapy Administration | Office | 140 | 77 | $27.41 | $3,838 |
| 36415 Venipuncture Blood Collection | Office | 137 | 128 | $8.65 | $1,185 |
| 76872 Ultrasound - Nonspecific | Office | 90 | 84 | $115.39 | $10K |
| 99212 Office E&M - Established | Office | 84 | 74 | $46.10 | $3,873 |
| 99203 Office E&M - New | Office | 82 | 82 | $81.58 | $6,690 |
By year: 2022 $595K for 18,478 services; 2023 $888K for 15,080 services; 2024 $878K for 14,378 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 859 | 570 | $2.19 | $1,881 |
| 87086 Bacterial Culture | 166 | 132 | $7.86 | $1,305 |
| 87088 Bacterial Culture | 161 | 128 | $7.91 | $1,274 |
| 36415 Venipuncture Blood Collection | 137 | 128 | $8.65 | $1,185 |
| 87077 Bacterial Culture | 53 | 39 | $7.82 | $414 |
| 87186 General Laboratory | 51 | 38 | $8.36 | $427 |
| 84153 Clinical Chemistry | 15 | 13 | $18.02 | $270 |
| 81001 Clinical Chemistry | 12 | 12 | $3.11 | $37.32 |
Medicare prescription drug claims, 2024
In 2024, the drug Gordon A Brown prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,569 prescriptions and refills. In total Gordon A Brown wrote 5,449 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,569 | 4,251 | 533 | $31K |
| Orgovyx Relugolix | 389 | 389 | 55 | $1.1M |
| Abiraterone Acetate Generic | 383 | 399 | 53 | $796K |
| Prednisone Generic | 348 | 412 | 58 | $3,226 |
| Dutasteride Generic | 254 | 677 | 68 | $9,832 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 235 | 247 | 168 | $2,354 |
| Finasteride Generic | 192 | 566 | 64 | $2,658 |
| Erleada Apalutamide | 191 | 193 | 23 | $2.6M |
| Cefadroxil Generic | 183 | 183 | 155 | $889 |
| Nubeqa Darolutamide | 183 | 185 | 27 | $2.4M |
| Myrbetriq Mirabegron | 144 | 307 | 37 | $132K |
| Silodosin Generic | 122 | 316 | 41 | $10K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 112 | 323 | 39 | $3,143 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 79 | 79 | 67 | $200 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 61 | 119 | 17 | $802 |
Brand drugs: - claims; generic drugs: 4,332 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gordon A Brown $245K ($245K in general payments such as food, travel and fees) from 20 companies. The largest payer was Janssen Biotech, Inc. with $76K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 72 | $76K |
| AstraZeneca Pharmaceuticals LP AZN | 32 | $52K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 19 | $29K |
| Astellas Pharma US Inc 4503.T | 14 | $23K |
| Pfizer Inc. PFE | 17 | $21K |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $19K |
| Novartis Pharmaceuticals Corporation NVS | 8 | $8,294 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $7,320 |
| Urogen Pharma, Inc. URGN | 2 | $3,305 |
| Ferring Pharmaceuticals Inc. | 3 | $2,865 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.